PLX

#3115
Protalix BioTherapeutics, Inc. Common Stock
2.8300 USD
+1.07%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
2.7890
2.8450
Faixa anual
2.5850
3.1900
Mudança diária
+1.07%
Mudança mensal
-3.08%
Mudança em 6 meses
-3.08%
Mudança anual
-3.08%
Fechamento anterior
2.8000
Open
2.8200
Bid
2.8300
Ask
2.8330
Low
2.7890
High
2.8450
Volume
288
Open full chart

Financials

Overview Relatórios Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25

Protalix BioTherapeutics Inc (DE)

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

Notícias